// App-Quantinova.ai

Su1400 : Impact of Patient Weight on Adalimumab Efficacy in Crohn's Disease - a Pilot Study

Researchers

Presenter

  • Uri Kopylov

Principal Investigators

  • Matthew Strohl

  • Laurence Paradis-Surprenant

  • Mohanad K. Almaimani

  • Myriam Martel

  • Alain Bitton

  • Waqqas Afif

  • Talat Bessissow

  • Ernest G. Seidman

Medical Centers

  • Medicine & Pediatrics, GI Division, McGill University Health Center, Montreal, Quebec, Canada

  • McGill University Health Centre, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Inflammatory bowel disease

  • Rheumatoid arthritis

  • Crohn's disease

  • Inflammatory Arthritis

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved